Florian Kron

671 total citations
40 papers, 181 citations indexed

About

Florian Kron is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Florian Kron has authored 40 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Florian Kron's work include Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers) and CAR-T cell therapy research (6 papers). Florian Kron is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Lung Cancer Treatments and Mutations (6 papers) and CAR-T cell therapy research (6 papers). Florian Kron collaborates with scholars based in Germany, Spain and France. Florian Kron's co-authors include Anna Kron, Kai Hübel, Oliver A. Cornely, Michael Hallek, Michael P. Lux, Helmut Ostermann, Richard Noppeney, Bertram Glaß, Gary Milkovich and Mohamad Mohty and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Florian Kron

33 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Kron Germany 8 67 46 39 37 32 40 181
Íñigo Romón Spain 9 40 0.6× 49 1.1× 42 1.1× 29 0.8× 14 0.4× 29 255
Kibum Jeon South Korea 9 86 1.3× 61 1.3× 64 1.6× 16 0.4× 48 1.5× 35 301
Peter Georgantopoulos United States 8 78 1.2× 72 1.6× 47 1.2× 19 0.5× 13 0.4× 21 224
Magdalini Bristianou Greece 7 103 1.5× 19 0.4× 102 2.6× 53 1.4× 40 1.3× 11 259
Lidija Kitanovski Slovenia 7 69 1.0× 24 0.5× 89 2.3× 15 0.4× 19 0.6× 24 203
Ruth de Francisco Spain 10 65 1.0× 38 0.8× 148 3.8× 28 0.8× 17 0.5× 29 303
Ingolf Mølle Denmark 9 30 0.4× 77 1.7× 75 1.9× 62 1.7× 40 1.3× 21 246
Sergio Di Matteo Italy 10 42 0.6× 67 1.5× 64 1.6× 10 0.3× 19 0.6× 31 244
Xiucui Han China 8 35 0.5× 137 3.0× 38 1.0× 40 1.1× 23 0.7× 13 287
Marie Chauveau France 6 78 1.2× 106 2.3× 120 3.1× 15 0.4× 13 0.4× 7 253

Countries citing papers authored by Florian Kron

Since Specialization
Citations

This map shows the geographic impact of Florian Kron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Kron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Kron more than expected).

Fields of papers citing papers by Florian Kron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Kron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Kron. The network helps show where Florian Kron may publish in the future.

Co-authorship network of co-authors of Florian Kron

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Kron. A scholar is included among the top collaborators of Florian Kron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Kron. Florian Kron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tresckow, Bastian von, Hans Christian Reinhardt, Christian Jehn, et al.. (2024). How to optimize the CAR-T Cell therapy process? A group concept mapping analysis of preconditions for a frictionless process from a German multistakeholder perspective. Frontiers in Oncology. 14. 1466803–1466803. 1 indexed citations
2.
Camacho, Luísa, et al.. (2024). Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost Effectiveness and Resource Allocation. 22(1). 21–21. 1 indexed citations
3.
4.
5.
Kron, Anna, et al.. (2023). Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre. Mycoses. 66(5). 405–411. 1 indexed citations
6.
7.
Lehmann, Clara, et al.. (2023). Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis. Journal of Infection and Public Health. 16(6). 955–963. 2 indexed citations
8.
9.
10.
Kron, Anna, et al.. (2022). Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontier. Cost Effectiveness and Resource Allocation. 20(1). 4 indexed citations
11.
Kron, Anna, Sebastian Michels, Lucia Nogová, et al.. (2022). 991P EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of TP53 mutation status and value of immune checkpoint blockade (ICB). Annals of Oncology. 33. S1006–S1006. 1 indexed citations
12.
13.
Kron, Anna, Santiago Grau, David Enoch, et al.. (2021). Reimbursement of innovative pharmaceuticals in English and Spanish hospitals—The example of isavuconazole. Mycoses. 64(10). 1213–1222. 2 indexed citations
14.
15.
16.
Koehler, Philipp, Sibylle C. Mellinghoff, Jannik Stemler, et al.. (2019). Quantifying guideline adherence in mucormycosis management using the EQUAL score. Mycoses. 63(4). 343–351. 11 indexed citations
17.
Kron, Anna, Richard Riedel, Sebastian Michels, et al.. (2017). Impact of co-occurring genomic alterations on overall survival of BRAF V600E and non-V600E mutated NSCLC patients: Results of the Network Genomic Medicine. Annals of Oncology. 28. v461–v462. 6 indexed citations
18.
Mohty, Mohamad, Nabih Azar, Christian Chabannon, et al.. (2017). Plerixafor in poor mobilizers with non-Hodgkin’s lymphoma: a multi-center time-motion analysis. Bone Marrow Transplantation. 53(3). 246–254. 23 indexed citations
19.
Kron, Florian, Matthias Scheffler, Dolores T. Müller, et al.. (2017). Economic burden of clinical trials in lung cancer in a German Comprehensive Cancer Center. Lung Cancer. 108. 134–139. 1 indexed citations
20.
Michels, Sebastian, Jana Fassunke, Matthias Scheffler, et al.. (2016). Survival following implementation of next-generation sequencing in routine diagnostics of advanced lung cancer: Results of the German Network Genomic Medicine.. Journal of Clinical Oncology. 34(15_suppl). 9085–9085. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Íñigo Romón Breakdown of academic impact, for papers by Kibum Jeon Breakdown of academic impact, for papers by Peter Georgantopoulos Breakdown of academic impact, for papers by Magdalini Bristianou Breakdown of academic impact, for papers by Lidija Kitanovski Breakdown of academic impact, for papers by Ruth de Francisco Breakdown of academic impact, for papers by Ingolf Mølle Breakdown of academic impact, for papers by Sergio Di Matteo Breakdown of academic impact, for papers by Xiucui Han Breakdown of academic impact, for papers by Marie Chauveau
Rankless by CCL
2026